Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nenad Biorac"'
Autor:
Yamada Tetsuji, Nemanja Rancic, Dejana Savic, Chia Ching, Goran Mihajlović, Katarina Nikic-Djuricic, Mirjana Jovanovic, Slobodan M. Jankovic, Mihajlo Jakovljevic, Nenad Biorac, Dejan Stevanovic
Publikováno v:
Hospital Pharmacology, Vol 2, Iss 1, Pp 235-245 (2015)
Background and Objectives There is a paucity of published cost-effectiveness studies of alternative scenarios in depressive episode acute medical care in Eastern European populations. Methods Prospective cost-effectiveness analysis was conducted on 6
Autor:
Aleksandra Aleksic, Sladjana Rakovic, Nenad Biorac, Marina Kostić, Ivan Stevanovic, Ivana Mihajlovic, Marko Folić, Radosava Vuckovic, M Slobodan Jankovic, Jelena Aleksic, Marija Radosavljevic, Natasa Stefanovic-Stoimenov, Danka Tesic, Jelena Borlja
Publikováno v:
Vojnosanitetski Pregled, Vol 66, Iss 7, Pp 556-562 (2009)
Scopus-Elsevier
Scopus-Elsevier
Background/Aim. A cost-effectiveness analyses of immunomodulatory treatments for relapsing-remitting multiple sclerosis (RRMS) in developed countries have shown that any benefit from these drugs is achieved at very high cost. The aim of our study was
Publikováno v:
Vojnosanitetski Pregled, Vol 66, Iss 4, Pp 271-276 (2009)
Background/Aim. High morbidity and mortality rates, chronic course of disease and numerous clinical complications, make diabetes mellitus (DM) type 2 bear significant financial burden for healthcare system of Serbia. The aim of this study was to comp
Autor:
Mihajlo Jakovljevic, K. Nikic Djuricic, Nenad Biorac, Dejan Stevanovic, Goran Mihajlović, Snezana V. Jankovic, C.H.E.N. Chia Ching, Tetsuji Yamada, Mirjana Jovanovic
Publikováno v:
European Psychiatry. 29:1
Introduction There is paucity of published literature on antidepressants in a cost-consequence study design. Objectives Measuring clinical outcomes of pharmacotherapy. Aims Costs and consequences determination in depressive episode acute medical care